C
08158
China Regenerative Medicine Inte…
0.86
0.08+10.26%Closed13:27 09/02 HKT
OPEN/PREV CLOSE0.850/0.780
TODAY RANGE0.850-0.930
VOL310.15K
MARKET CAP261.66M
52 WEEK RANGE0.094-1.270
AVG VOL (3M)384.51K
% TURNOVER0.10%
TURNOVER277.98K
P/E (TTM)204.762
% RANGE10.26%
EPS(TTM)0.004
P/E(FORWARD)--
P/B9.005
BVPS0.096
DIVIDEND--
P/S4.493
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP261.66M
SHARES OUTSTANDING304.25M
NEXT EARNINGS11/13-11/17
FREE FLOAT304.25M
LOT SIZE5000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·08/22 11:33
CHINA REGENERATIVE MEDICINE INTERNATIONAL H1 REVENUE HKD 27.39 MILLION
Simply Wall St·07/07 22:35
China Regenerative Medicine International Limited (HKG:8158) Surges 35% Yet Its Low P/S Is No Reason For Excitement
Simply Wall St·06/27 23:12
Is China Regenerative Medicine International Limited (HKG:8158) A High Quality Stock To Own?
Simply Wall St·05/23 22:34
Why Investors Shouldn't Be Surprised By China Regenerative Medicine International Limited's (HKG:8158) 27% Share Price Plunge
Simply Wall St·05/15 01:17
China Regenerative Medicine International (HKG:8158) Seems To Use Debt Quite Sensibly
Simply Wall St·04/09 22:02
April 2025's Promising Asian Penny Stocks
Simply Wall St·04/08 22:23
Improved Revenues Required Before China Regenerative Medicine International Limited (HKG:8158) Stock's 26% Jump Looks Justified
Simply Wall St·03/31 00:46
China Regenerative Medicine International Full Year 2024 Earnings: EPS: HK$0.058 (vs HK$0.38 loss in FY 2023)
Reuters·03/28 13:13
CHINA REGENERATIVE MEDICINE INTERNATIONAL FY GROSS PROFIT HKD 57.65 MILLION
Simply Wall St·11/13/2024 03:05
China Regenerative Medicine International And 2 Other Promising Penny Stocks
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.